BioPharma Dive - Latest News

Cidara stock soars as antiviral drug succeeds in flu study

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu prevention.

Jun 23, 2025 - 17:45
 0
Cidara stock soars as antiviral drug succeeds in flu study

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu prevention.

Read More

Tags:

Previous Article

J&J launches daily disposable contact lens for astigmatism, presbyopia

Next Article

Novo abruptly ends obesity drug deal with Hims

Related Posts

Merck antibody drug for RSV approved by FDA

Merck antibody drug for RSV approved by FDA

Jun 9, 2025  0

Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer

Zepzelca, Tecentriq combo extends survival in hard-to-t...

May 22, 2025  0

GLP-1 prescriptions for weight loss soar, despite obstacles

GLP-1 prescriptions for weight loss soar, despite obsta...

May 28, 2025  0